KindlyMD (NAKA) Competitors $12.30 -1.00 (-7.52%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NAKA vs. VMD, TOI, DCGO, XGN, EUDA, SERA, QIPT, KDLY, ATPC, and CORBFShould you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include Viemed Healthcare (VMD), Oncology Institute (TOI), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Kindly MD (KDLY), Agape ATP (ATPC), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry. KindlyMD vs. Its Competitors Viemed Healthcare Oncology Institute DocGo Exagen EUDA Health Sera Prognostics Quipt Home Medical Kindly MD Agape ATP Global Cord Blood KindlyMD (NASDAQ:NAKA) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk. Which has stronger earnings & valuation, NAKA or VMD? Viemed Healthcare has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindlyMD$2.72M27.27-$3.62M-$0.77-15.97Viemed Healthcare$224.26M1.19$11.27M$0.3022.47 Which has more risk & volatility, NAKA or VMD? KindlyMD has a beta of 35.16, indicating that its share price is 3,416% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Do institutionals & insiders have more ownership in NAKA or VMD? 74.2% of Viemed Healthcare shares are held by institutional investors. 50.5% of KindlyMD shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to NAKA or VMD? In the previous week, KindlyMD had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Viemed Healthcare. KindlyMD's average media sentiment score of 0.94 beat Viemed Healthcare's score of 0.65 indicating that KindlyMD is being referred to more favorably in the media. Company Overall Sentiment KindlyMD Positive Viemed Healthcare Positive Is NAKA or VMD more profitable? Viemed Healthcare has a net margin of 5.28% compared to KindlyMD's net margin of -177.01%. Viemed Healthcare's return on equity of 9.49% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets KindlyMD-177.01% -146.26% -109.19% Viemed Healthcare 5.28%9.49%7.14% SummaryViemed Healthcare beats KindlyMD on 8 of the 13 factors compared between the two stocks. Get KindlyMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAKA vs. The Competition Export to ExcelMetricKindlyMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$80.19M$7.37B$5.62B$9.09BDividend YieldN/A2.81%5.24%4.00%P/E Ratio-15.9734.5428.1820.27Price / Sales27.2735.57428.7098.42Price / CashN/A23.3737.4658.16Price / Book28.606.858.045.49Net Income-$3.62M$236.02M$3.19B$250.45M7 Day Performance-3.53%0.01%3.62%4.79%1 Month Performance-27.52%0.25%4.06%7.68%1 Year PerformanceN/A33.80%30.01%16.43% KindlyMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAKAKindlyMDN/A$12.30-7.5%N/AN/A$80.19M$2.72M-15.97N/AVMDViemed Healthcare1.3842 of 5 stars$7.02+2.2%N/A+2.4%$271.53M$224.26M23.401,179TOIOncology Institute1.7287 of 5 stars$2.50-2.3%$7.00+180.0%+579.0%$228.44M$393.41M-3.57660Positive NewsDCGODocGo2.2095 of 5 stars$1.55+2.0%$3.56+129.7%-51.0%$155.01M$616.55M-77.504,407XGNExagen3.3278 of 5 stars$6.95-0.1%$7.50+7.9%+261.2%$148.25M$55.64M-8.27220Positive NewsGap DownHigh Trading VolumeEUDAEUDA Health1.2863 of 5 stars$3.35+0.6%N/A-16.2%$123.73M$4.01M0.002SERASera Prognostics0.4165 of 5 stars$2.72+12.4%N/A-54.3%$91.17M$80K-2.89120News CoverageHigh Trading VolumeQIPTQuipt Home Medical3.199 of 5 stars$1.80+4.0%$2.85+58.3%-37.9%$75.16M$245.91M-8.571,200Analyst RevisionKDLYKindly MDN/A$12.04-5.6%N/A+434.1%$72.51M$2.47M-15.64N/AGap UpATPCAgape ATP0.5516 of 5 stars$1.39-0.5%N/A-62.8%$69.76M$1.32M-2.3140News CoverageGap DownCORBFGlobal Cord BloodN/A$0.55+0.1%N/A-37.5%$66.91M$196.12M0.001,200 Related Companies and Tools Related Companies Viemed Healthcare Alternatives Oncology Institute Alternatives DocGo Alternatives Exagen Alternatives EUDA Health Alternatives Sera Prognostics Alternatives Quipt Home Medical Alternatives Kindly MD Alternatives Agape ATP Alternatives Global Cord Blood Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAKA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAKA Stock Alerts